Overview
Status
Active
Registry date
2017-03-02
Registered address
ul. Juliusza Słowackiego 1, 59-400 Jawor, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 94 days late).
- 202502/06/2026
- 202414/07/2025
- 202312/07/2024
- 202210/07/2023
- 202117/10/2022
- 202001/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 3.06mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 2.66kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 3.05mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 532.17kMedianUSD 544.32kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
Expressmed has been an NFZ healthcare provider since 2025. In 2026 it is performing 1 contract worth USD 363.50. All its contracts were worth USD 937.67 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | dolnośląskie | 1 | USD 363.50 |
Partners
| Partners | Partner role | Limited partner contribution |
|---|---|---|
| General partner | – | |
Patryk Dorobekage 42 | Limited partner | 5000 PLN |
Kamil Abramekage 42 | Limited partner | 5000 PLN |
Piotr Jerzy Strzeleckiage 51 | Limited partner | 5000 PLN |
Manner of representation
General partner independently
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-10-03.
40 2490 0005 0000 4600 2724 5163
63 2490 0005 0000 4500 9490 3365
98 2490 0005 0000 4610 8952 0801
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $35,659.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,497$3,497 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,520$3,520 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 14, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $25,232$25,232 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cefarm RzeszówS.A. | $28,356,418.72 | cefarmrzeszow.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl |
FAQ
The main business activity of Expressmed sp. z o.o. sp.k. focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on March 2, 2017.
The headquarters is located at: ul. Juliusza Słowackiego 1, 59-400 Jawor.
The legal form of this entity is a limited partnership (sp. z o.o. sp.k.).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $3,056,687, representing an increase of 1.9% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $2,661, meaning the company decreased its profit by 94.3%.
The largest operating cost category falls under other operating costs. This category amounted to $2,550,204 in 2025, representing 84% of all operating expenses.
Last updated: 2026-06-03